Background: Surgical interventions such as posterior lumbar interbody fusion (PLIF) with and without posterior instrumentation are often employed in patients with degenerative spinal conditions that fail to respond to conservative medical management. The VariLift® Interbody Fusion System was developed as a stand-alone solution to provide the benefits of an intervertebral fusion device without the requirement of supplemental pedicle screw fixation.
AUSTIN, TX February 22, 2017 –Wenzel Spine, Inc., a medical technology company focused on providing minimally invasive solutions for the treatment of spinal disorders, today announced that it has completed the acquisition of the PrimaLOK™ SP Interspinous Fusion System and PrimaLOK™ FF Facet Fixation System from OsteoMed, LLC.
AUSTIN, TX Jan 18, 2017 – Wenzel Spine, Inc., a medical technology company focused on providing minimally invasive solutions for the treatment of spinal disorders, today announced it has moved their corporate office and distribution operations to a new facility in Austin, TX. This new facility, located at 1130 Rutherford Lane, Suite 200, Austin, TX 78753, provides over 15,000 square feet of office and warehouse space.
Dr. Mannas and Dr. Tibbs from the University of Kentucky, have been using VariLift-L Stand-Alone and have just completed a case study for one of their patients. The poster was presented at SNS 2016. Click through to see the full poster presentation.
Company Continues Expansion of Expandable Stand-Alone Portfolio
AUSTIN, TX April 29, 2016 – Wenzel Spine, Inc., a pioneer medical device company focused on providing minimally invasive, expandable stand-alone alternatives to traditional spinal fusion, announced today the full commercial availability of the VariLift®-LX System throughout the U.S.
Wenzel Spine, Inc. Announces FDA Clearance to Launch VariLift®-LX - The Next Generation Zero-Profile Stand-Alone Expandable Lumbar Interbody Fusion Device
AUSTIN, TX Feb 11, 2016 – Wenzel Spine, Inc., a pioneer medical
device company focused on providing minimally invasive, stand-alone
alternatives to traditional spinal fusion, announced today that it
received clearance from the U.S. Food and Drug Administration (FDA) to
market VariLift®-LX as an interbody fusion device for stand-alone use in the lumbar spine.